{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:07Z","timestamp":1785412507131,"version":"3.56.0"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04ev03g22","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Swedish Heart and Lung Foundation","award":["20190556"],"award-info":[{"award-number":["20190556"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20241168"],"award-info":[{"award-number":["20241168"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20220168"],"award-info":[{"award-number":["20220168"]}]},{"award":["20190556"],"award-info":[{"award-number":["20190556"]}],"id":[{"id":"https:\/\/ror.org\/052261q33","id-type":"ROR","asserted-by":"publisher"}]},{"award":["20241168"],"award-info":[{"award-number":["20241168"]}],"id":[{"id":"https:\/\/ror.org\/052261q33","id-type":"ROR","asserted-by":"publisher"}]},{"award":["20220168"],"award-info":[{"award-number":["20220168"]}],"id":[{"id":"https:\/\/ror.org\/052261q33","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2019\u201301673"],"award-info":[{"award-number":["2019\u201301673"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2019\u201301673"],"award-info":[{"award-number":["2019\u201301673"]}],"id":[{"id":"https:\/\/ror.org\/03zttf063","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background and aims: Abdominal aortic aneurysm (AAA) is a vascular disease characterized by the progressive dilation of the aorta, culminating in rupture. At present, there are no pharmacological treatments to prevent AAA development or reduce rupture rate. A recent study showed that patients prescribed Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have significantly lower risks of mortality, AAA repair, and acute abdominal aortic syndrome. Semaglutide is a GLP-1RA with increased agonist capacity and longer half-life, compared to earlier generations of GLP-1RAs. In this study, we aimed to investigate the role and mechanisms of semaglutide in the prevention of AAA development and rupture in a murine model. Methods: AAA was induced in apolipoprotein-E-deficient mice, by continuous subcutaneous infusion of angiotensin II. Treatment with semaglutide (12 \u00b5g\/kg) began seven days after disease induction (rescue trial) or simultaneously with disease induction (prophylactic trial). At experimental endpoint, aortic diameter was measured by high-frequency ultrasound and the aortic tissue was collected for histological analysis. Results: Prophylactic treatment with semaglutide drastically reduced mortality by dissection and rupture during the first seven days of disease development, but did not affect AAA formation at 28 days. Histological evaluation of the aorta at day seven showed a normal vessel wall thickness with a trend for a higher content of collagen in the aortic wall in mice treated with semaglutide, compared to controls. Conclusions: Semaglutide prevents aortic rupture and dissection in the early phases of AAA development in the angiotensin II mouse model, likely by promoting the maintenance of an adequate proportion of collagen in the vessel wall.<\/jats:p>","DOI":"10.3390\/biomedicines14040933","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:22:47Z","timestamp":1776691367000},"page":"933","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-1724","authenticated-orcid":false,"given":"Amanda","family":"Balboa Ramilo","sequence":"first","affiliation":[{"name":"Department of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-8726","authenticated-orcid":false,"given":"Anders","family":"Wanhainen","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-5251","authenticated-orcid":false,"given":"Henrik","family":"Lod\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malou","family":"Friederich-Persson","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3655-2419","authenticated-orcid":false,"given":"Dick","family":"W\u00e5gs\u00e4ter","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms","volume":"67","author":"Wanhainen","year":"2024","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41572-018-0030-7","article-title":"Abdominal aortic aneurysms","volume":"4","author":"Sakalihasan","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin Prescription Associated with Reduced Abdominal Aortic Aneurysm Growth Rate and Reduced Chemokine Expression in a Swedish Cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann. Vasc. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejvs.2020.11.048","article-title":"The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) Trial","volume":"61","author":"Wanhainen","year":"2021","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Knudsen, L.B., and Lau, J. (2019). The Discovery and Development of Liraglutide and Semaglutide. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00155"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rowlands, J., Heng, J., Newsholme, P., and Carlessi, R. (2018). Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00672"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e020231","DOI":"10.1161\/JAHA.120.020231","article-title":"Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression","volume":"10","author":"Gabel","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biochi.2018.06.026","article-title":"Glucagon-Like peptide-1: A new therapeutic target to treat abdominal aortic aneurysm?","volume":"152","author":"Raffort","year":"2018","journal-title":"Biochimie"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jvs.2025.11.021","article-title":"Glucagon-like peptide-1 receptor agonists are associated with reduced abdominal aortic aneurysm-related events","volume":"83","author":"Ahn","year":"2025","journal-title":"J. Vasc. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(\u2212\/\u2212) and LDLr(\u2212\/\u2212) Mice by a Mechanism That Includes Inflammatory Pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2022.07.034","article-title":"Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice","volume":"622","author":"Pan","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yue, L., Chen, S., Ren, Q., Niu, S., Pan, X., Chen, X., Li, Z., and Chen, X. (2022). Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.995007"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1021\/acs.analchem.5c00633","article-title":"Met-ID: An Open-Source Software for Comprehensive Annotation of Multiple On-Tissue Chemical Modifications in MALDI-MSI","volume":"97","author":"Bjarterot","year":"2025","journal-title":"Anal. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: The Human Metabolome Database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"D527","DOI":"10.1093\/nar\/gkl838","article-title":"LMSD: LIPID MAPS structure database","volume":"35","author":"Sud","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"D1677","DOI":"10.1093\/nar\/gkad896","article-title":"LIPID MAPS: Update to databases and tools for the lipidomics community","volume":"52","author":"Conroy","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00595-015-1287-z","article-title":"Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats","volume":"46","author":"Yu","year":"2016","journal-title":"Surg. Today"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10557-023-07456-x","article-title":"Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better","volume":"38","author":"Zhao","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bph.15462","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor","volume":"179","author":"Helmstadter","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J.P., Liu, X., Previs, S., Willard, B., Smith, J.D., and McCullough, A. (2015). Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126910"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jvs.2015.12.056","article-title":"Inflammatory cells, ceramides, and expression of proteases in perivascular adipose tissue adjacent to human abdominal aortic aneurysms","volume":"65","author":"Folkesson","year":"2017","journal-title":"J. Vasc. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Saito, A., Ishimori, N., Tokuhara, S., Homma, T., Nishikawa, M., Iwabuchi, K., and Tsutsui, H. (2021). Activation of Invariant Natural Killer T Cells by alpha-Galactosylceramide Attenuates the Development of Angiotensin II-Mediated Abdominal Aortic Aneurysm in Obese ob\/ob Mice. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.659418"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/933\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:23:00Z","timestamp":1776946980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biomedicines14040933"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14040933","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]}}}